Dyne Therapeutics, Inc. Free Cash Flow

Free Cash Flow of DYN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Free Cash Flow growth rates and interactive chart. Free cash flowis calculated as operating cash flow minus of capital expenditures. Interest payments are excluded from the generally accepted definition of free cash flow. Free cash flow is the cash flow available to all the investors in a company, including common stockholders, preferred shareholders, and lenders. Some investors prefer FCF or FCF per share over earnings and earnings per share as a measure of profitability. However, because FCF accounts for investments in property, plant, and equipment it can be lumpy over time. Free cash flow is usually used in discounted cash flow models to determine a company's intrinsic value.

Highlights and Quick Summary

  • Free Cash Flow for the quarter ending June 30, 2023 was $-55.9 Million (a 18.57% increase compared to previous quarter)
  • Year-over-year quarterly Free Cash Flow increased by 27.93%
  • Annual Free Cash Flow for 2022 was $-157 Million (a 27.22% increase from previous year)
  • Annual Free Cash Flow for 2021 was $-123 Million (a 158.41% increase from previous year)
  • Annual Free Cash Flow for 2020 was $-47.7 Million (a 253.6% increase from previous year)
  • Twelve month Free Cash Flow ending June 30, 2023 was $-176 Million (a 16.3% increase compared to previous quarter)
  • Twelve month trailing Free Cash Flow increased by 12.33% year-over-year
Trailing Free Cash Flow for the last four month:
30 Jun '23 31 Mar '23 31 Dec '22 30 Sep '22
$-176 Million $-152 Million $-157 Million $-157 Million
Visit stockrow.com/DYN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Free Cash Flow of Dyne Therapeutics, Inc.

Most recent Free Cash Flowof DYN including historical data for past 10 years.

Interactive Chart of Free Cash Flow of Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc. Free Cash Flow for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $-55.89 $-47.14 – – –
2022 $-29.71 $-43.69 $-31.17 $-52.14 $-156.71
2021 $-30.06 $-27.83 $-46.89 $-18.4 $-123.18
2020 $-20.76 $-12.04 $-7.37 $-7.5 $-47.67
2019 – – $-4.75 $-8.73 $-13.48
2018 – – – – $-4.16

Business Profile of Dyne Therapeutics, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com